{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:18:34Z","timestamp":1794003514903,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-alcoholic steatohepatitis (NASH) is an epidemic metabolic disease with limited therapeutic strategies. Cumulative data support the pivotal role of gut microbiota in NASH. Here, we investigated the hypothesis regarding whether fecal microbiota transplantation (FMT) is effective in attenuating high-fat diet (HFD)-induced steatohepatitis in mice. Mice were randomized into control, HFD and HFD\u2009+\u2009FMT groups. After an 8-week HFD, FMT treatment was initiated and carried out for 8 weeks. The gut microbiota structure, butyrate concentrations of the cecal content, liver pathology and intrahepatic lipid and cytokines were examined. Our results showed that after FMT, the gut microbiota disturbance was corrected in HFD-fed mice with elevated abundances of the beneficial bacteria\n                    <jats:italic>Christensenellaceae<\/jats:italic>\n                    and\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    . FMT also increased butyrate concentrations of the cecal content and the intestinal tight junction protein ZO-1, resulting in relief of endotoxima in HFD-fed mice. Steatohepatitis was alleviated after FMT, as indicated by a significant decrease in intrahepatic lipid accumulation (reduced Oli-red staining, decreased intrahepatic triglyceride and cholesterol), intrahepatic pro-inflammatory cytokines, and the NAS score. Accordingly, intrahepatic IFN-\u03b3 and IL-17 were decreased, but Foxp3, IL-4 and IL-22 were increased after FMT intervention. These data indicate that FMT attenuated HFD-induced steatohepatitis in mice via a beneficial effect on the gut microbiota.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-01751-y","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T06:06:49Z","timestamp":1493705209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":394,"title":["Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota"],"prefix":"10.1038","volume":"7","author":[{"given":"Da","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-gao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"issue":"2263","key":"1751_CR1","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella, M. E. Nonalcoholic Fatty Liver Disease. Jama \n                           313(2263), 5370\u201373, doi:10.1001\/jama.2015.5370 (2015).","journal-title":"Jama"},{"key":"1751_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1499-3872(15)60026-1","volume":"14","author":"P Gkolfakis","year":"2015","unstructured":"Gkolfakis, P., Dimitriadis, G. & Triantafyllou, K. Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International \n                           14, 572\u2013581 (2015).","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"1751_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/gutjnl-2015-309990","volume":"65","author":"JR Marchesi","year":"2016","unstructured":"Marchesi, J. R. et al. The gut microbiota and host health: a new clinical frontier. Gut \n                           65, 330\u2013339, doi:10.1136\/gutjnl-2015-309990 (2016).","journal-title":"Gut"},{"key":"1751_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.numecd.2012.02.007","volume":"22","author":"D Compare","year":"2012","unstructured":"Compare, D. et al. Gut\u2013liver axis: The impact of gut microbiota on non alcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases \n                           22, 471\u2013476, doi:10.1016\/j.numecd.2012.02.007 (2012).","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"},{"key":"1751_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1053\/j.gastro.2013.08.058","volume":"145","author":"LP Smits","year":"2013","unstructured":"Smits, L. P., Bouter, K. E. C., de Vos, W. M., Borody, T. J. & Nieuwdorp, M. Therapeutic Potential of Fecal Microbiota Transplantation. Gastroenterology \n                           145, 946\u2013953, doi:10.1053\/j.gastro.2013.08.058 (2013).","journal-title":"Gastroenterology"},{"key":"1751_CR6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/hepr.12671","volume":"46","author":"X Gao","year":"2016","unstructured":"Gao, X., Zhu, Y., Wen, Y., Liu, G. & Wan, C. Efficacy of probiotics in nonalcoholic fatty liver disease in adult and children: A meta-analysis of randomized controlled trials. Hepatology Research \n                           46, 1226\u20131233, doi:10.1111\/hepr.v46.12 (2016).","journal-title":"Hepatology Research"},{"key":"1751_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12291-011-0121-7","volume":"26","author":"SK Das","year":"2011","unstructured":"Das, S. K. & Balakrishnan, V. Role of Cytokines in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. Indian Journal of Clinical Biochemistry \n                           26, 202\u2013209, doi:10.1007\/s12291-011-0121-7 (2011).","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"1751_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"LV Hooper","year":"2012","unstructured":"Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions Between the Microbiota and the Immune System. Science \n                           336, 1268\u20131273, doi:10.1126\/science.1223490 (2012).","journal-title":"Science"},{"key":"1751_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature11551","volume":"489","author":"CL Maynard","year":"2012","unstructured":"Maynard, C. L., Elson, C. O., Hatton, R. D. & Weaver, C. T. Reciprocal interactions of the intestinal microbiota and immune system. Nature \n                           489, 231\u2013241, doi:10.1038\/nature11551 (2012).","journal-title":"Nature"},{"key":"1751_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4161\/gmic.19320","volume":"3","author":"H-J Wu","year":"2014","unstructured":"Wu, H.-J. & Wu, E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes \n                           3, 4\u201314, doi:10.4161\/gmic.19320 (2014).","journal-title":"Gut Microbes"},{"key":"1751_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nature13793","volume":"514","author":"J Suez","year":"2014","unstructured":"Suez, J. et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature \n                           514, 181\u2013186, doi:10.1038\/nature13793 (2014).","journal-title":"Nature"},{"key":"1751_CR12","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","volume":"75","author":"PD Schloss","year":"2009","unstructured":"Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol \n                           75, 7537\u20137541, doi:10.1128\/AEM.01541-09 (2009).","journal-title":"Appl Environ Microbiol"},{"key":"1751_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jaci.2012.10.026","volume":"131","author":"M Noval Rivas","year":"2013","unstructured":"Noval Rivas, M. et al. A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis. J Allergy Clin Immunol \n                           131, 201\u2013212, doi:10.1016\/j.jaci.2012.10.026 (2013).","journal-title":"J Allergy Clin Immunol"},{"key":"1751_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00248-013-0238-8","volume":"66","author":"XT Jiang","year":"2013","unstructured":"Jiang, X. T. et al. Illumina sequencing of 16S rRNA tag revealed spatial variations of bacterial communities in a mangrove wetland. Microb Ecol \n                           66, 96\u2013104, doi:10.1007\/s00248-013-0238-8 (2013).","journal-title":"Microb Ecol"},{"key":"1751_CR15","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol \n                           12, R60, doi:10.1186\/gb-2011-12-6-r60 (2011).","journal-title":"Genome Biol"},{"key":"1751_CR16","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch, S. V., Phimister, E. G. & Pedersen, O. The Human Intestinal Microbiome in Health and Disease. New England Journal of Medicine \n                           375, 2369\u20132379, doi:10.1056\/NEJMra1600266 (2016).","journal-title":"New England Journal of Medicine"},{"key":"1751_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.gie.2013.03.1329","volume":"78","author":"LJ Brandt","year":"2013","unstructured":"Brandt, L. J. & Aroniadis, O. C. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointestinal Endoscopy \n                           78, 240\u2013249, doi:10.1016\/j.gie.2013.03.1329 (2013).","journal-title":"Gastrointestinal Endoscopy"},{"key":"1751_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology \n                           143, 913\u2013916 e917, doi:10.1053\/j.gastro.2012.06.031 (2012).","journal-title":"Gastroenterology"},{"key":"1751_CR19","doi-asserted-by":"publisher","first-page":"E1306","DOI":"10.1073\/pnas.1518189113","volume":"113","author":"J Li","year":"2016","unstructured":"Li, J. et al. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci USA \n                           113, E1306\u20131315, doi:10.1073\/pnas.1518189113 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1751_CR20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/ismej.2015.151","volume":"10","author":"R Berni Canani","year":"2016","unstructured":"Berni Canani, R. et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J \n                           10, 742\u2013750, doi:10.1038\/ismej.2015.151 (2016).","journal-title":"ISME J"},{"key":"1751_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature12506","volume":"500","author":"E Le Chatelier","year":"2013","unstructured":"Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature \n                           500, 541\u2013546, doi:10.1038\/nature12506 (2013).","journal-title":"Nature"},{"key":"1751_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1079\/PNS2002207","volume":"62","author":"S Macfarlane","year":"2007","unstructured":"Macfarlane, S. & Macfarlane, G. T. Regulation of short-chain fatty acid production. Proceedings of the Nutrition Society \n                           62, 67\u201372, doi:10.1079\/PNS2002207 (2007).","journal-title":"Proceedings of the Nutrition Society"},{"key":"1751_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1017\/S0954422410000247","volume":"23","author":"P Guilloteau","year":"2010","unstructured":"Guilloteau, P. et al. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutrition Research Reviews \n                           23, 366\u2013384, doi:10.1017\/S0954422410000247 (2010).","journal-title":"Nutrition Research Reviews"},{"key":"1751_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1749-6632.2012.06553.x","volume":"1258","author":"S Pl\u00f6ger","year":"2012","unstructured":"Pl\u00f6ger, S. et al. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Annals of the New York Academy of Sciences \n                           1258, 52\u201359, doi:10.1111\/j.1749-6632.2012.06553.x (2012).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"1751_CR25","doi-asserted-by":"publisher","unstructured":"Engen, P. A. et al. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy. Journal of Parkinson\u2019s Disease. 1\u201316, doi:10.3233\/JPD-160991 (2017).","DOI":"10.3233\/JPD-160991"},{"key":"1751_CR26","doi-asserted-by":"publisher","unstructured":"Nova, E., Perez de Heredia, F., Gomez-Martinez, S. & Marcos, A. The Role of Probiotics on the Microbiota: Effect on Obesity. Nutr Clin Pract \n                           31, 387\u2013400, doi:10.1177\/0884533615620350 (2016).","DOI":"10.1177\/0884533615620350"},{"key":"1751_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.metabol.2015.10.008","volume":"65","author":"AK Mishra","year":"2016","unstructured":"Mishra, A. K., Dubey, V. & Ghosh, A. R. Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota. Metabolism \n                           65, 48\u201365, doi:10.1016\/j.metabol.2015.10.008 (2016).","journal-title":"Metabolism"},{"key":"1751_CR28","doi-asserted-by":"publisher","first-page":"39026","DOI":"10.1038\/srep39026","volume":"6","author":"S-Y Cho","year":"2016","unstructured":"Cho, S.-Y. et al. Modulation of gut microbiota and delayed immunosenescence as a result of syringaresinol consumption in middle-aged mice. Scientific Reports \n                           6, 39026, doi:10.1038\/srep39026 (2016).","journal-title":"Scientific Reports"},{"key":"1751_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/nu8110733","volume":"8","author":"J Roberts","year":"2016","unstructured":"Roberts, J. et al. An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic\/Prebiotic, Antioxidant Intervention. Nutrients \n                           8, 733, doi:10.3390\/nu8110733 (2016).","journal-title":"Nutrients"},{"key":"1751_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11255-016-1430-9","volume":"49","author":"S-Y Choi","year":"2016","unstructured":"Choi, S.-Y. et al. The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells. International Urology and Nephrology \n                           49, 171\u2013181, doi:10.1007\/s11255-016-1430-9 (2016).","journal-title":"International Urology and Nephrology"},{"key":"1751_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.fct.2014.08.010","volume":"73","author":"S Khan","year":"2014","unstructured":"Khan, S. & Jena, G. Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-beta1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats. Food Chem Toxicol \n                           73, 127\u2013139, doi:10.1016\/j.fct.2014.08.010 (2014).","journal-title":"Food Chem Toxicol"},{"key":"1751_CR32","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.bcp.2007.08.023","volume":"74","author":"R Bulow","year":"2007","unstructured":"Bulow, R. et al. Antifibrogenic effects of histone deacetylase inhibitors on pancreatic stellate cells. Biochem Pharmacol \n                           74, 1747\u20131757, doi:10.1016\/j.bcp.2007.08.023 (2007).","journal-title":"Biochem Pharmacol"},{"key":"1751_CR33","doi-asserted-by":"crossref","unstructured":"Stenman, L. K., Burcelin, R. & Lahtinen, S. Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans \u2013 towards treatment with probiotics. Beneficial Microbes, 1\u201312 (2015).","DOI":"10.3920\/BM2015.0069"},{"key":"1751_CR34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","volume":"159","author":"JuliaK Goodrich","year":"2014","unstructured":"Goodrich, Julia, K. et al. Human Genetics Shape the Gut Microbiome. Cell \n                           159, 789\u2013799, doi:10.1016\/j.cell.2014.09.053 (2014).","journal-title":"Cell"},{"key":"1751_CR35","doi-asserted-by":"publisher","first-page":"30887","DOI":"10.1038\/srep30887","volume":"6","author":"M-J Jung","year":"2016","unstructured":"Jung, M.-J. et al. Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice. Scientific Reports \n                           6, 30887, doi:10.1038\/srep30887 (2016).","journal-title":"Scientific Reports"},{"key":"1751_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ismej.2014.99","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. The ISME Journal \n                           9, 1\u201315, doi:10.1038\/ismej.2014.99 (2014).","journal-title":"The ISME Journal"},{"key":"1751_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrmicro2974","volume":"11","author":"F Sommer","year":"2013","unstructured":"Sommer, F. & B\u00e4ckhed, F. The gut microbiota \u2014 masters of host development and physiology. Nature Reviews Microbiology \n                           11, 227\u2013238, doi:10.1038\/nrmicro2974 (2013).","journal-title":"Nature Reviews Microbiology"},{"key":"1751_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11154-016-9339-2","volume":"17","author":"M Nati","year":"2016","unstructured":"Nati, M. et al. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord \n                           17, 29\u201339, doi:10.1007\/s11154-016-9339-2 (2016).","journal-title":"Rev Endocr Metab Disord"},{"key":"1751_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.intimp.2006.08.015","volume":"7","author":"J-S Park","year":"2007","unstructured":"Park, J.-S., Lee, E.-J., Lee, J.-C., Kim, W.-K. & Kim, H.-S. Anti-inflammatory effects of short chain fatty acids in IFN-\u03b3-stimulated RAW 264.7 murine macrophage cells: Involvement of NF-\u03baB and ERK signaling pathways. International Immunopharmacology \n                           7, 70\u201377, doi:10.1016\/j.intimp.2006.08.015 (2007).","journal-title":"International Immunopharmacology"},{"key":"1751_CR40","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith, P. M. et al. The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis. Science \n                           341, 569\u2013573, doi:10.1126\/science.1241165 (2013).","journal-title":"Science"},{"key":"1751_CR41","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1017\/S0007114515003621","volume":"114","author":"CJ Jin","year":"2015","unstructured":"Jin, C. J., Sellmann, C., Engstler, A. J., Ziegenhardt, D. & Bergheim, I. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH). British Journal of Nutrition \n                           114, 1745\u20131755, doi:10.1017\/S0007114515003621 (2015).","journal-title":"British Journal of Nutrition"},{"key":"1751_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky, J. M. & Glass, C. K. Macrophages, Inflammation, and Insulin Resistance. Annual Review of Physiology \n                           72, 219\u2013246, doi:10.1146\/annurev-physiol-021909-135846 (2010).","journal-title":"Annual Review of Physiology"},{"key":"1751_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ni1018","volume":"5","author":"D Kelly","year":"2004","unstructured":"Kelly, D. et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol \n                           5, 104\u2013112, doi:10.1038\/ni1018 (2004).","journal-title":"Nat Immunol"},{"key":"1751_CR44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.intimp.2014.09.024","volume":"23","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. 3, 3\u2032-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg\/Th17 cells to Treg dominance. Int Immunopharmacol \n                           23, 489\u2013498, doi:10.1016\/j.intimp.2014.09.024 (2014).","journal-title":"Int Immunopharmacol"},{"key":"1751_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20150405","volume":"130","author":"S Rolla","year":"2016","unstructured":"Rolla, S. et al. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. Clin Sci (Lond) \n                           130, 193\u2013203, doi:10.1042\/CS20150405 (2016).","journal-title":"Clin Sci (Lond)"},{"key":"1751_CR46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrendo.2012.114","volume":"8","author":"H Sell","year":"2012","unstructured":"Sell, H., Habich, C. & Eckel, J. Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol \n                           8, 709\u2013716, doi:10.1038\/nrendo.2012.114 (2012).","journal-title":"Nat Rev Endocrinol"},{"key":"1751_CR47","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/hep.21823","volume":"46","author":"X Ma","year":"2007","unstructured":"Ma, X. et al. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology \n                           46, 1519\u20131529, doi:10.1002\/hep.21823 (2007).","journal-title":"Hepatology"},{"key":"1751_CR48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10875-011-9635-2","volume":"32","author":"NE Ferreyra Solari","year":"2012","unstructured":"Ferreyra Solari, N. E. et al. The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis. J Clin Immunol \n                           32, 611\u2013621, doi:10.1007\/s10875-011-9635-2 (2012).","journal-title":"J Clin Immunol"},{"key":"1751_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2249.2011.04471.x","volume":"166","author":"Y Tang","year":"2011","unstructured":"Tang, Y. et al. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clin Exp Immunol \n                           166, 281\u2013290, doi:10.1111\/j.1365-2249.2011.04471.x (2011).","journal-title":"Clin Exp Immunol"},{"key":"1751_CR50","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/abbs\/gmt065","volume":"45","author":"R Xu","year":"2013","unstructured":"Xu, R., Tao, A., Zhang, S. & Zhang, M. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice. Acta Biochim Biophys Sin (Shanghai) \n                           45, 726\u2013733, doi:10.1093\/abbs\/gmt065 (2013).","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1751_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s13277-015-4294-1","volume":"37","author":"M Saalim","year":"2016","unstructured":"Saalim, M. et al. IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma. Tumour Biol \n                           37, 105\u2013114, doi:10.1007\/s13277-015-4294-1 (2016).","journal-title":"Tumour Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01751-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01751-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01751-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T22:59:41Z","timestamp":1671749981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01751-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1751"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01751-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]},"assertion":[{"value":"31 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1529"}}